Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1126/sciimmunol.abd5709 http://scihub22266oqcxt.onion/10.1126/sciimmunol.abd5709 32727884!7594018!32727884     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Immunol 2020 ; 5 (49): ä Nephropedia Template TP {{tp|p=32727884|t=2020. SARS-CoV-2 seroprevalence among parturient women in Philadelphia |pdf=|usr=}}{{32727884}} gab.com Text SARS-CoV-2 seroprevalence among parturient women in Philadelphia JO: Sci Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32727884 #FOAvip Limited data are available for pregnant women affected by SARS-CoV-2. Serological tests are critically important for determining SARS-CoV-2 exposures within both individuals and populations. We validated a SARS-CoV-2 spike receptor binding domain serological test using 834 pre-pandemic samples and 31 samples from COVID-19 recovered donors. We then completed SARS-CoV-2 serological testing of 1,293 parturient women at two centers in Philadelphia from April 4 to June 3, 2020. We found 80/1,293 (6.2%) of parturient women possessed IgG and/or IgM SARS-CoV-2-specific antibodies. We found race/ethnicity differences in seroprevalence rates, with higher rates in Black/non-Hispanic and Hispanic/Latino women. Of the 72 seropositive women who also received nasopharyngeal polymerase chain reaction testing during pregnancy, 46 (64%) were positive. Continued serologic surveillance among pregnant women may inform perinatal clinical practices and can potentially be used to estimate exposure to SARS-CoV-2 within the community. Twit Text FOAVip SARS-CoV-2 seroprevalence among parturient women in Philadelphia ????Sci Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32727884 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32727884 #FOAvip English Wikipedia <ref>{{Cite pmid|32727884}}</ref> SARS-CoV-2 seroprevalence among parturient women in Philadelphia #MMPMID32727884 Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE Sci Immunol 2020[Jul]; 5 (49): ä PMID32727884show ga Limited data are available for pregnant women affected by SARS-CoV-2. Serological tests are critically important for determining SARS-CoV-2 exposures within both individuals and populations. We validated a SARS-CoV-2 spike receptor binding domain serological test using 834 pre-pandemic samples and 31 samples from COVID-19 recovered donors. We then completed SARS-CoV-2 serological testing of 1,293 parturient women at two centers in Philadelphia from April 4 to June 3, 2020. We found 80/1,293 (6.2%) of parturient women possessed IgG and/or IgM SARS-CoV-2-specific antibodies. We found race/ethnicity differences in seroprevalence rates, with higher rates in Black/non-Hispanic and Hispanic/Latino women. Of the 72 seropositive women who also received nasopharyngeal polymerase chain reaction testing during pregnancy, 46 (64%) were positive. Continued serologic surveillance among pregnant women may inform perinatal clinical practices and can potentially be used to estimate exposure to SARS-CoV-2 within the community. |*Health Status Disparities[MESH] |Adult[MESH] |Antibodies, Viral/*blood/immunology[MESH] |Betacoronavirus/immunology/*isolation & purification[MESH] |Black or African American/statistics & numerical data[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques/methods/statistics & numerical data[MESH] |Cohort Studies[MESH] |Coronavirus Infections/blood/diagnosis/*epidemiology/immunology/virology[MESH] |Female[MESH] |Hispanic or Latino/statistics & numerical data[MESH] |Humans[MESH] |Immunoglobulin G/blood/immunology[MESH] |Immunoglobulin M/blood/immunology[MESH] |Pandemics[MESH] |Philadelphia/epidemiology[MESH] |Pneumonia, Viral/blood/*epidemiology/immunology/virology[MESH] |Pregnancy[MESH] |Pregnancy Complications, Infectious/blood/*epidemiology/immunology/virology[MESH] |Protein Domains/immunology[MESH] |SARS-CoV-2[MESH] |Seroepidemiologic Studies[MESH] |Spike Glycoprotein, Coronavirus/immunology[MESH]SARS-CoV-2 seroprevalence among parturient women in Philadelphia (epmc).pdf DeepDyve Pubget Overpricing